Current Research into Cures for Type-1 Diabetes

Every year in September or October I write a blog posting which summarizes all research being done in humans, aimed at curing type-1 diabete...

More News on Rituximab Background on the drug: Rituximab targets the CD20 part of the immune system's B cells (different from the pan...

Rilonacept Starts a phase-I Clinical Trial About six months ago, I blogged about three clinical trials which had not yet started, but wer...

This is a "hat trick" of new drugs preparing to enter phase-II trials for type-1 diabetes.  Each one of these has started the p...